In our cohort we identified COL4A variants including COL4A3, COL4A4, COL4A5, in nine patients, which mainly affect glycine residue in patients with a diagnosis of idiopathic FSGS. This evidence concerns the gene COL4A3 and focal segmental glomerulosclerosis.